Skip to main content

Eduard Batlle: "CRISPR/Cas9 is a truly cutting-edge technique for biomedicine”

Images

Participants

Contact

Image
Press & Communications Section Head
Tel.+34 93 40 37255
The coordinator of the Oncology Programme and head of the Colorectal Cancer Lab at IRB Barcelona, Eduard Batlle, has talked to the EFE Agency about the award of “Princesa de Asturias en Ciencia y Tecnología 2015” to Emmanuelle Charpentier and Jennifer Doudna for the development of the CRISPR/Cas9 gene-editing technique.
Attachment:

About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).